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Background: The cognitive consequences of carbon monoxide (CO) poisoning are well described. However, most
studies have been carried out without an ad-hoc group of control subjects. The main aim of this study was to
evaluate cognitive and psychiatric outcome after CO exposure during the storm Klaus in the South West of France
(January 2009) in a homogeneous group of patients compared to a group of 1:1 paired controls.
Methods: Patients and controls were asked to fill out questionnaires about quality of life and cognitive complaints.
They then underwent a cognitive assessment derived from the Carbon Monoxide Neuropsychological Screening
Battery. Psychiatric assessment was performed using subtests of the Mini International Neuropsychiatric Interview.
Results: 38 patients and 38 paired controls were included (mean age 38.8 years) and evaluated 51 days after the
poisoning. No difference was found between groups on the cognitive complaint questionnaire but patients had a
lower quality of life than controls. Patients showed significantly lower cognitive performance than controls on
processing speed, mental flexibility, inhibition and working and verbal episodic memories. Patients were more
depressed than controls, and suffered more from post-traumatic stress disorder.
Conclusions: We report the first study investigating cognitive and psychiatric outcome in consecutive patients after
CO poisoning during a natural disaster, using a group comparison method. CO poisoning during storms needs to
be dealt with adequately and clinicians should be aware of its possible consequences.
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The cognitive consequences of carbon monoxide (CO)
poisoning are well described [1]. They can be observed
during the acute phase of the poisoning, after a few days
and persist for over a year [2-6]. They mainly involve
memory, attention, processing speed and executive
functions [6]. However, most studies have been carried
out without an ad-hoc group of control subjects, mainly
relying on published norms for comparison [7,8].* Correspondence: jeremie.pariente@inserm.fr
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unless otherwise stated.Interestingly, Deschamps et al. did not evidence any
difference between patients and controls when a spe-
cific group of controls was recruited [9]. These last
studies gathered patients with variable circumstances
of CO intoxication, which may be the reason for their
heterogeneous results, but which also questions the ex-
tent to which results apply to all patients. It was to
avoid these limitations that we carried out the present
study in a homogenous group of intoxicated patients
using rigorously selected control subjects.
The storm Klaus reached the South West of France
between 23rd and 25th January 2009 leaving 1,745,000
households without electricity. It is considered to be the
most violent storm in France in the past decade, result-
ing in 1.2 billion Euros of structural damage. Alternativetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tors, were used and resulted in increased CO poisoning.
117 persons were poisoned in the Midi-Pyrenean region
and referenced by the local specialized center.
The main aim of this study was to evaluate cognitive
and psychiatric outcome after CO exposure during the
Klaus storm in a homogeneous group of patients and to
compare the results with those obtained in a group of con-




We contacted 117 poisoned patients by phone to invite
them to participate in the present study. We invited
them to attend an outpatient clinic for a cognitive andFigure 1 Group comparisons for education level and the five cognitiv
of each test, we provide a graphical representation of the dispersion of the
and 75th percentiles, and the lines in the boxes indicate the medians. Notc
lower lines of whiskers represent minimum and maximum performance. Ci
outside minimum or maximum values of +/- 1.5 the difference between th
significant difference (*: p < 0.05 and **: p < 0.01).psychiatric assessment in the Purpan hospital, Toulouse,
France.
Patients were eligible for the study if they met the
following criteria: 1) A diagnosis of CO poisoning ac-
cording to the published criteria of documented expos-
ure to carbon monoxide or obvious exposure to carbon
monoxide with observation of any of the following
symptoms: loss of consciousness, confusion, headache,
malaise, fatigue, forgetfulness, dizziness, visual distur-
bances, nausea, vomiting, cardiac ischemia, or metabolic
acidosis [6]. If the carboxyhemoglobin level was below 10
percent, the patient was eligible only if carbon monoxide
poisoning was the only plausible diagnosis, 2) Above 15
years of age, 3) French language abilities good enough to
undergo the assessment, 4) Signed informed consent.
Non-inclusion criteria were: patients admitted to a nursinge tests that showed significant differences. For the main measure
performance of each group using box-plots. Boxes represent the 25th
hes display the variability of the median between samples. Upper and
rcles are outliers in each group, i.e. subjects whose performance fell
e 25th and 75th percentiles. D represents Cohen’s D value. *indicates a
Table 1 Causes of CO poisoning, initial symptoms and
symptoms observed during the study










Loss of consciousness 29%
Cardiac ischemia 10%
Severe ketoacidosis 3%
Acute pulmonary edema 3%








Reduction of daily activities 26%
Still on sick leave 24%
*No patient presented paralysis, ventricular arrhythmia, convulsion, shock,
coma, stroke or rhabdomyolysis as initial symptoms. No brain lesions assessed
by CT scan was reported.
Pages et al. BMC Neurology 2014, 14:153 Page 3 of 6
http://www.biomedcentral.com/1471-2377/14/153home, patients with a preexisting chronic neurological
illness or with depression or post-traumatic stress dis-
order, patients with a life threatening condition and
patients with hypoxia due to a chemical intoxication.
Patients who suffered from any medical condition, other
intoxication or brain traumatism between CO poisoning
and the assessment in the present study were not in-
cluded. When possible, carboxyhemoglobin (COHb) level
was recorded. A CT scan was performed when necessary
at the acute phase.
Procedure
The included patients were asked to fill out cognitive
complaint and quality of life questionnaires [10,11].
They then underwent general and neurological clinical
examinations, which included a semi-structured inter-
view. A cognitive assessment derived from the Carbon
Monoxide Neuropsychological Screening Battery was
performed: Free and Cued Selective Reminding Test
(FCSRT) for verbal episodic memory, WAIS-III Letter-
Number Sequencing for working memory, MEM-III
orientation test, WAIS-III Digit Symbol Test, TMT A
and B, Stroop test for executive functions, and confron-
tation naming test for language [4]. In accordance with
the literature, 8 specific variables of interest were identi-
fied within this battery: the cued and total 3 recall of the
FCSRT (score/48), the raw score for Letter-Number
Sequencing (/21), the raw score of the orientation test
(/14), the raw score for digit substitution in the Digit
Symbol Test (/133), time in seconds for TMT B-A,
reading time in seconds for the score interference part
of the Stroop test and the raw score for naming in the
confrontation naming test (/10) [6-8]. Psychiatric assess-
ment was performed using subtests of the Mini Inter-
national Neuropsychiatric Interview (M.I.N.I. 5.0.0): major
depressive episode (MDE), manic episode, hypomanic
episode, post-traumatic stress disorder (PTSD), psychotic
disorders, and antisocial personality disorder [12]. The
total time of the evaluation was approximately 1 hour.
A group of controls not exposed to carbon monoxide
was enrolled in the study. They were relatives of patients
seen in our memory clinic. They were paired 1:1 to pa-
tients for age, gender, and level of education. Controls
received exactly the same evaluation tests as patients.
Patients and controls gave their informed consent for
this study. The study was approved by the local ethics
committee (“Comité d’Ethique de la Recherche” of the
Toulouse teaching hospital “CHU de Toulouse”, France).
Statistical analysis
We performed an intergroup comparison on demographic
and clinical data using bilateral Student t tests for inde-
pendent samples, non-parametric Mann-Whitney U tests
when a Kolmogorov-Smirnov test indicated that thesample did not follow a normal distribution, or a chi2 test
when appropriate. Effect size was estimated using Cohen’s
D [13] when a significant difference was observed. Follow-
ing conventional criteria, an effect size of 0.20 to 0.30 was
considered “small”, around 0.50 “medium” and above 0.80
“large”. In the patients’ group, we used Spearman correl-
ation between COHb level and cognitive composite score.
The cognitive composite score was generated from the 8
specific variables of interest previously identified (the cued
and total 3 recall of the FCSRT, the raw score for Letter-
Number Sequencing, the raw score for the orientation
test, the raw score for digit substitution in the Digit
Symbol Test, time in seconds for TMT B-A, reading time
in seconds for the score interference part of the Stroop
test and the raw score for naming in the confrontation
naming test). For each of the 8 variables, the patients’
scores were standardized according to the group average
of the variable. Then, the cognitive composite score was
calculated as the mean of the 8 standardized cognitive
scores. The lower the cognitive composite score, the more
Table 2 Patients’ and controls’ cognitive, psychiatric and global scores
Patients Controls p value Cohen’s D
(n = 38) (n = 38)
Cognitive assessment
Disorientation in time and space (MEM III)
MEM III, orientation (/14) 13.76 (±0.48) 13.86 (±0.34) 0.281 -
Memory
Free recall
FCRST (sum of 3 free recall, /48) 11.21 (±2.30) 11.86 (±2.32) 0.048 0.47
FCRST (delayed free recall, /16) 13 (±2.02) 13.92 (±1.51) 0.028 0.52
Cued recall
FCSRT (sum of 3 total recall, /48) 14.63 (±1.66) 15.36 (±0.88) 0.030 0.55
FCSRT (delayed total recall, /16) 15.63 (±0.91) 15.92 (±0.35) 0.073 -
Executive functions
Processing speed
TMT A time 36.73 (±17.64) 31.13 (±12.04) 0.110 -
Stroop test (denomination time) 64.21 (±14.58) 59.05 (±8.39) 0.063 -
Stroop test (reading time) 48.31 (±10.07) 41.71 (±6.54) 0.001 0.79
Digit symbol test (/133) 67.92 (±17.80) 76.71 (±17.74) 0.034 0.49
Working memory
Letter-Number sequencing (WAIS III, /21) 9.97 (±2.56) 11.36 (±2.36) 0.016 0.57
Flexibility
TMTB time 36.73 (±17.64) 31.13 (±12.04) 0.010 0.63
TMT B-A time 54.55 (±43.57) 32.24 (±24.13) 0.008 0.64
TMT B-A Errors 0.08 (±0.68) 0.13 (±0.34) 0.685 -
Inhibition
Stroop test (interference score, time) 59.65 (±38.36) 39.86 (±21.37) 0.007 0.61
Stroop test (interference score, non-corrected errors) 0.47 (±1.51) 0.02 (±0.16) 0.013 0.59
Language
Denomination (/10) 9.95(±0.23) 9.95 (±0.23) 1.000 -
Psychiatric assessment
MNI, major depressive episode, n (%) 8 (21.05%) 0 0.003 -
MNI, manic episode, n (%) 2 (5.26%) 1 (2.63%) 0.556 -
MNI, hypomanic episode, n (%) 2 (5.26%) 0 0.152 -
MNI, post-traumatic stress disorder, n (%) 6 (15.78%) 0 0.011 -
MNI, psychotic disorders, n (%) 1 (2.63%) 0 0.314 -
MNI, antisocial personality disorder, n (%) 0 0 - -
Global assessment
Cognitive complaints
Mc Nair score (/45) 11.56 (±7.97) 13.52 (±5.00) 0.206 -
Quality of life
MOS SF-36, Total (/135) 103.81 (±18.37) 113.42 (±9.29) 0.020 0.69
MEM III, Wechsler Memory Scale; FCRST, Free and Cued Selective Reminding Test ; WAIS III, Wechsler Adult Intelligence Scale; TMT, Trail Making Test; MINI, Mini
International Neuropsychiatric Interview; MOS SF-36, Medical outcome Study Short Form 36.
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statistically significant.
Results
Among the 117 patients, 30 were children under 15 who
were not contacted. 87 patients were contacted by phone
between February 25th and 27th 2009. 7 did not meet the
inclusion criteria. The 80 remaining persons were con-
tacted and invited to participate. 42 persons did not
want to enter the study and explained they had resumed
their life with no sequelae. 38 persons were included
(mean age 38.9 ± 16.6; 34.2% male; 11.7 ± 2.9 years of
education). 38 paired controls were also recruited (mean
age 38.7 ± 16.5; 34.2 % male; 11.4 ± 3.9 years of educa-
tion). No difference was found between patients and
controls for age, gender and education level (Figure 1,
data reported for education). Patients were assessed for
the study 50.9 ± 17.3 days after CO poisoning. They all
fulfilled the CO poisoning diagnosis criteria. The COHb
level was recorded for 24 out of the 38 patients (10.9%
(±7.9)). No CT scan lesion was observed. 2 patients (5%)
had received hyperbaric oxygen therapy, 6 (16%) had
had normobaric oxygen therapy and 29 (76%) had re-
ceived both. For 1 patient, the treatment received was
not known. Causes of CO intoxication, initial symptoms
and symptoms reported during the semi-structured
interview are reported in Table 1.
No difference was found between groups on the cogni-
tive complaint questionnaire but patients had a lower
quality of life than controls (patients: 103.8 ± 18.3; con-
trols: 113.4 ± 9.2; p < 0.001; Table 2). Patients showed
significantly lower cognitive performance than controls
on 5/8 of the following cognitive variables of interest:
FCSRT, letter-number sequences, digit symbol test, TMT
B test, Stroop test (Figure 1). The effect size was “medium”
for all these tests (Figure 1). Different results between the
two groups were identified in two of the six subtests of theFigure 2 Spearman correlation between COHb level and cognitive coM.I.N.I.: major depressive disorder (p < 0.01) and PTSD
(p < 0.02) were more common in the patient group
(Table 2).
We found a negative correlation between patients’
COHb level and cognitive composite score (r = -0,42,
p < 0,005) (Figure 2).
Discussion
In this controlled study, patients were all poisoned dur-
ing the same weather event and over a very short period
of time (3 days). They were enrolled and assessed about
7 weeks after the intoxication. In this homogeneous
group of patients, we evidenced both cognitive and psy-
chiatric sequelae after CO poisoning.
Performance was significantly lower in patients than in
controls in five out of the eight cognitive variables of
interest, despite the fact that controls and patients had
been rigorously matched. Three of the variables assessed
processing speed and executive functions, one working
memory and one verbal episodic memory. These results
suggest that these patients were suffering from multi-
domain cognitive impairment. We are aware of only two
studies in which a group of patients was compared to a
group of matched controls specifically enrolled for the
study [9,2]. Surprisingly, in Deschamps’ study no cogni-
tive difference was reported between the two groups but
not all the patients underwent cognitive assessment [9].
Significant differences were showed in Chen’s study but
neuropsychological assessment was only partial and mem-
ory function had not been assessed [2]. Other studies in-
vestigating cognitive outcome after CO poisoning did not
specifically enroll a group of control subjects but reported
results that are in accordance with ours [5,7,14,15]. We
acknowledge that our study is cross-sectional. Therefore
we did not address the delayed neuropsychological impair-
ment issue. The cause of intoxication may be the reason
for this apparent difference as previous studies have oftenmposite score.
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during suicide attempts, which is a more severe exposure
than the involuntary intoxication that happened in our
sample.
Psychiatric sequelae such as anxiety and depression
have only been reported in a few studies [8,14]. Patients
in our sample also reported PTSD after CO poisoning.
This is congruent with the patients’ complaints about
their reviviscences.
It is possible that the recruitment method was a factor
of bias. The 42 intoxicated persons who did not enter
the study might have had lower cognitive impairment
compared to the 38 recruited intoxicated participants.
Therefore, the size of the observed effects in our analysis
is possibly overestimated. However, we have shown that
cognitive complaint was as low in the patient group as it
was in the group of controls. We acknowledge that if the
recruitment method was not ideal, its influence on the
results was probably weak.Conclusions
We report here the first study investigating cognitive
and psychiatric outcome in consecutive patients after
CO poisoning during a natural disaster. Using a group
comparison method, we confirmed the potential multi-
domain cognitive nature of sequelae PTSD is one aspect
that is also to be taken into account after that specific
intoxication. In spite of the medium size effect reported
in this study, patients as a group reported a lower quality
of life, which may have been caused by these cognitive
and psychiatric sequelae. CO poisoning during storms
must therefore be dealt with adequately and clinicians
should be aware of its possible consequences.
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